β-catenin interacts with and inhibits NF-κB in human colon and breast cancer

[1]  T. Gilmore,et al.  Immortalized embryonic mouse fibroblasts lacking the RelA subunit of transcription factor NF-κB have a malignantly transformed phenotype , 2002, Oncogene.

[2]  D. Longo,et al.  Linking β-Catenin to Androgen-signaling Pathway* , 2002, The Journal of Biological Chemistry.

[3]  S. Korsmeyer,et al.  Bax Loss Impairs Myc-Induced Apoptosis and Circumvents the Selection of p53 Mutations during Myc-Mediated Lymphomagenesis , 2001, Molecular and Cellular Biology.

[4]  G. Cheng,et al.  Enhanced sensitivity to apoptosis in Ras-transformed thyroid cells , 2001, Oncogene.

[5]  M. Oren,et al.  Deregulated β‐catenin induces a p53‐ and ARF‐dependent growth arrest and cooperates with Ras in transformation , 2001, The EMBO journal.

[6]  Ye Zheng,et al.  NF-κB RelA (p65) Is Essential for TNF-α-Induced Fas Expression but Dispensable for Both TCR-Induced Expression and Activation-Induced Cell Death1 , 2001, The Journal of Immunology.

[7]  Marty W. Mayo,et al.  WNT-1 Signaling Inhibits Apoptosis by Activating β-Catenin/T Cell Factor–Mediated Transcription , 2001, The Journal of cell biology.

[8]  E Yoshida,et al.  Regulation of Lef-mediated Transcription and p53-dependent Pathway by Associating β-Catenin with CBP/p300* , 2000, The Journal of Biological Chemistry.

[9]  E. Fearon,et al.  Regulation of β-catenin transformation by the p300 transcriptional coactivator , 2000 .

[10]  M. Merville,et al.  Nuclear factor-kappa B, cancer, and apoptosis. , 2000, Biochemical pharmacology.

[11]  M. Evans,et al.  Overexpression of beta-catenin induces apoptosis independent of its transactivation function with LEF-1 or the involvement of major G1 cell cycle regulators. , 2000, Molecular biology of the cell.

[12]  S. Scherer,et al.  Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kγ , 2000, Nature.

[13]  P. Polakis.  Wnt signaling and cancer. , 2000, Genes & development.

[14]  J. Woodgett,et al.  Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation , 2000, Nature.

[15]  Bernd R. Binder,et al.  Dynamics of NF κB and IκBα Studied with Green Fluorescent Protein (GFP) Fusion Proteins , 2000, The Journal of Biological Chemistry.

[16]  F. Shanahan,et al.  Altered Mechanisms of Apoptosis in Colon Cancer: Fas Resistance and Counterattack in the Tumor‐Immune Conflict , 2000, Annals of the New York Academy of Sciences.

[17]  K. Vousden,et al.  Role of NF-κB in p53-mediated programmed cell death , 2000, Nature.

[18]  Kris Vleminckx,et al.  The p300/CBP acetyltransferases function as transcriptional coactivators of β‐catenin in vertebrates , 2000, The EMBO journal.

[19]  M. Hung,et al.  β-Catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression , 2000 .

[20]  M. Hung,et al.  HER-2/neu Blocks Tumor Necrosis Factor-induced Apoptosis via the Akt/NF-κB Pathway* , 2000, The Journal of Biological Chemistry.

[21]  A. Kikuchi,et al.  Roles of Axin in the Wnt signalling pathway. , 1999, Cellular signalling.

[22]  A. Kahn,et al.  Intestinal dysplasia and adenoma in transgenic mice after overexpression of an activated beta-catenin. , 1999, Cancer research.

[23]  Paul Polakis,et al.  The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors , 1999, Oncogene.

[24]  Frank McCormick,et al.  β-Catenin regulates expression of cyclin D1 in colon carcinoma cells , 1999, Nature.

[25]  Ming Li,et al.  A Critical Role for the RelA Subunit of Nuclear Factor κB in Regulation of Multiple Immune-response Genes and in Fas-induced Cell Death , 1999, The Journal of experimental medicine.

[26]  L. Owen-Schaub,et al.  Activation-Dependent Transcriptional Regulation of the Human fas Promoter Requires NF-κB p50-p65 Recruitment , 1999, Molecular and Cellular Biology.

[27]  Paul Polakis,et al.  The oncogenic activation of β-catenin , 1999 .

[28]  K. Macleod.  pRb and E2f-1 in mouse development and tumorigenesis. , 1999, Current opinion in genetics & development.

[29]  B. Geiger,et al.  Differential molecular interactions of beta-catenin and plakoglobin in adhesion, signaling and cancer. , 1998, Current opinion in cell biology.

[30]  C. Y. Wang,et al.  NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. , 1998, Science.

[31]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[32]  J. Gordon,et al.  Effects of Forced Expression of an NH2-terminal Truncated β-Catenin on Mouse Intestinal Epithelial Homeostasis , 1998, The Journal of cell biology.

[33]  L. Butler,et al.  Down-regulation of Fas gene expression in colon cancer is not a result of allelic loss or gene rearrangement. , 1998, British Journal of Cancer.

[34]  W. Birchmeier,et al.  Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. , 1998, Science.

[35]  P. Möller,et al.  Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis. , 1998, Cancer research.

[36]  R. Nusse,et al.  β-catenin: a key mediator of Wnt signaling , 1998 .

[37]  K. Hunt,et al.  P53 Carcinoma Cell Lines and Does Not Require Factor E2f-1 Induces Apoptosis in Human Breast and Ovarian Adenovirus-mediated Overexpression of the Transcription Updated Version Citing Articles E-mail Alerts Adenovirus-mediated Overexpression of the Transcription Factor E2f-1 Induces Apoptosis in Hum , 2013 .

[38]  Stephen W. Byers,et al.  Serine Phosphorylation-regulated Ubiquitination and Degradation of β-Catenin* , 1997, The Journal of Biological Chemistry.

[39]  M. Gerritsen,et al.  CREB-binding protein/p300 are transcriptional coactivators of p65. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[40]  K. Kinzler,et al.  Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.

[41]  Hans Clevers,et al.  Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.

[42]  G. Nabel,et al.  Regulation of NF-κB by Cyclin-Dependent Kinases Associated with the p300 Coactivator , 1997, Science.

[43]  Marty W. Mayo,et al.  TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.

[44]  Michael Karin,et al.  Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death , 1996, Cell.

[45]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[46]  D. White,et al.  Rel/NF-kappaB/IkappaB proteins and cancer. , 1996, Oncogene.

[47]  D. McConkey,et al.  Ras signaling in tumor necrosis factor‐induced apoptosis. , 1996, The EMBO journal.

[48]  B. Gumbiner.  Signal transduction of beta-catenin. , 1995, Current opinion in cell biology.

[49]  T. McDonnell,et al.  Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis. , 1995, Oncogene.

[50]  D. Baltimore,et al.  I kappa B: a specific inhibitor of the NF-kappa B transcription factor. , 1988, Science.

[51]  Douglas B. Evans,et al.  The Nuclear Factor-κB RelA Transcription Factor Is Constitutively Activated in Human Pancreatic Adenocarcinoma Cells , 1999 .

[52]  M J May,et al.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.